TL;DR
A common gym supplement, creatine, may give cancer-fighting immune cells a vital energy boost by increasing their supply of ATP, the molecule that fuels cellular activity. This finding, reported on July 25, 2026, matters because it points to a simple, low-cost dietary strategy to potentially improve the effectiveness of immunotherapies like CAR‑T cell therapy, where tired immune cells often fail to sustain their attack on tumors.
What Happened
Scientists have discovered that creatine—the popular muscle‑building supplement found in powders and pills—could help supercharge cancer‑fighting immune cells by providing them with additional energy. The report, published by ScienceAlert on July 25, 2026, suggests that this everyday compound, already naturally produced in the body and widely used by athletes, may offer a new way to boost the endurance of T cells and other immune defenders in the fight against cancer.
Key Facts
- Creatine is a nitrogenous organic acid that the human body produces naturally, mostly in the liver, kidneys, and pancreas, at roughly 1 gram per day.
- The supplement is best known for enhancing the regeneration of adenosine triphosphate (ATP), the primary energy currency that powers all cellular processes.
- The report from ScienceAlert on July 25, 2026, highlights a new line of research exploring creatine’s potential to energize cancer‑fighting immune cells.
- Immune cells, particularly cytotoxic T lymphocytes, require vast amounts of ATP to proliferate, migrate, and kill tumor cells over sustained periods.
- Creatine is stored primarily in skeletal muscle, but its metabolic role extends to
